Showing 1 - 10 of 27
Persistent link: https://www.econbiz.de/10003331722
Persistent link: https://www.econbiz.de/10003542062
Persistent link: https://www.econbiz.de/10010516844
This paper provides estimates of the economic impact of non-communicable diseases (NCDs) in China and India for the period 2012-2030. Our estimates are derived using WHO's EPIC model of economic growth, which focuses on the negative effects of NCDs on labor supply and capital accumulation. We...
Persistent link: https://www.econbiz.de/10009792518
Persistent link: https://www.econbiz.de/10003529637
We propose a novel framework to analyse the macroeconomic impact of noncommunicable diseases. We incorporate measures of disease prevalence into a human capital augmented production function, which enables us to determine the economic costs of chronic health conditions in terms of foregone gross...
Persistent link: https://www.econbiz.de/10012951354
This paper provides estimates of the economic impact of non-communicable diseases (NCDs) in China and India for the period 2012-2030. Our estimates are derived using WHO's EPIC model of economic growth, which focuses on the negative effects of NCDs on labor supply and capital accumulation. We...
Persistent link: https://www.econbiz.de/10013076812
This paper provides estimates of the economic impact of non-communicable diseases (NCDs) in China and India for the period 2012-2030. Our estimates are derived using WHO's EPIC model of economic growth, which focuses on the negative effects of NCDs on labor supply and capital accumulation. We...
Persistent link: https://www.econbiz.de/10013077651
We propose a novel framework to analyse the macroeconomic impact of non-communicable diseases. We incorporate measures of disease prevalence into a human capital augmented production function, which enables us to determine the economic costs of chronic health conditions in terms of foregone...
Persistent link: https://www.econbiz.de/10011704338
We propose a novel framework to analyse the macroeconomic impact of noncommunicable diseases. We incorporate measures of disease prevalence into a human capital augmented production function, which enables us to determine the economic costs of chronic health conditions in terms of foregone gross...
Persistent link: https://www.econbiz.de/10011653537